Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

Carolin C Hack, Peter A Fasching, Tanja Fehm, Johann de Waal, Mahdi Rezai, Bernd Baier, Gerold Baake, Hans-Christian Kolberg, Martin Guggenberger, Mathias Warm, Nadia Harbeck, Rachel Wuerstlein, Jörg-Uwe Deuker, Peter Dall, Barbara Richter, Grischa Wachsmann, Cosima Brucker (Co-author), Jan W Siebers, Nikos Fersis, Thomas KuhnChristopher Wolf, Hans-Walter Vollert, Georg-Peter Breitbach, Wolfgang Janni, Robert Landthaler, Andreas Kohls, Daniela Rezek, Thomas Noesslet, Gunnar Fischer, Stefan Henschen, Thomas Praetz, Volker Heyl, Thorsten Kühn, Thomas Krauss, Christoph Thomssen, Andre Hohn, Hans Tesch, Christoph Mundhenke, Alexander Hein, Claudia Rauh, Christian M Bayer, Adib Jacob, Katja Schmidt, Erik Belleville, Peyman Hadji, Sara Y Brucker, Diethelm Wallwiener, Sherko Kümmel, Matthias W Beckmann, Daniela Paepke

Research output: Contribution to journalOriginal Articlepeer-review

24 Citations (Web of Science)
Original languageEnglish
Pages (from-to)165-175
JournalINTEGRATIVE CANCER THERAPIES
Volume16
Issue number2
DOIs
Publication statusPublished - 2017

Keywords

  • QUALITY-OF-LIFE
  • ALTERNATIVE MEDICINE
  • COMPLEMENTARY THERAPIES
  • GYNECOLOGIC ONCOLOGY
  • SYMPTOM MANAGEMENT
  • METABOLIC SYNDROME
  • WOMEN
  • SURVIVORS
  • CARE
  • CHEMOTHERAPY

Cite this